Nuvation Bio

Yahoo Finance • 12 days ago

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.

Investor Stanley Druckenmiller’s Duquesne Family Office exited a 385,000 share position in Alphabet in the first quarter. Continue Reading... Full story

Yahoo Finance • 14 days ago

Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer

Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States Move by Nuvation Bio further ensures critical drug supply for patients and providers NEW YORK, May 13,... Full story

Yahoo Finance • 22 days ago

Nuvation Bio's Supplemental NDA With Updated Data For IBTROZI Wins FDA Acceptance

(RTTNews) - Wednesday, Nuvation Bio Inc. (NUVB) announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application with updated data for IBTROZI for the treatment of advanced ROS1-positive non-small cell... Full story

Yahoo Finance • last month

Nuvation Bio Inc (NUVB): Take a Look at Glioma Revenue Potential

Nuvation Bio Inc (NYSE:NUVB) is among the must-buy penny stocks to invest in now. RBC Capital analysts see bright prospects for Nuvation Bio Inc (NYSE:NUVB) in the glioma treatment market, which they say is underserved. On April 6, RBC Cap... Full story

Yahoo Finance • last month

How Much Can Nuvation Bio (NUVB) Make From Ibtrozi Sales?

Nuvation Bio Inc. (NYSE:NUVB) is one of the best stock picks of billionaire David Abrams. Nuvation Bio Inc. (NYSE:NUVB) is also a favorite on the Street. The stock carries a Strong Buy rating with an average price target of $11.93, which i... Full story

Yahoo Finance • last month

Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks

Nuvation Bio Inc. (NYSE:NUVB) is one of the best healthcare penny stocks to buy according to hedge funds. On April 8, analysts at Truist Securities reiterated a Buy rating on Nuvation Bio Inc (NYSE:NUVB) with a $12 price target. The positi... Full story

Yahoo Finance • last month

FDA Priority Review And New Alliances Reshape Daiichi Sankyo Growth Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The FDA has accepted a Priority Review for Daiichi Sankyo and Merck’s biologics license application for ifinatamab deruxtec... Full story

Yahoo Finance • last month

Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights

Nuvation Bio Inc. (NYSE:NUVB) secures a spot on our list of the best penny stocks set to explode.Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights As of April 8, 2026, over 90% of covering analysts maintain their “... Full story

Yahoo Finance • 2 months ago

Nuvation Bio Inc. (NUVB) and Eisai Get EMA Validation for Taletrectinib

Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Stocks Under $10 to Buy and Hold Forever. On March 27, Nuvation Bio Inc. (NYSE:NUVB) and Eisai announced that the European Medicines Agency (EMA) validated the Marketing Authorisation Applic... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nuvation Bio Inc. (“Nuvation” or the “Company”) (NYSE: NUVB).  Such investors are advised to contact Danielle Peyton at newactio... Full story

Yahoo Finance • 3 months ago

Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch

Nuvation Bio Inc. (NYSE:NUVB) is one of the best low cost stocks to buy under $5. On March 2, Nuvation Bio (NUVB) reported a pivotal 2025 marked by the FDA approval and rapid commercial launch of Ibtrozi (Taletrectinib) for ROS1-positive n... Full story

Yahoo Finance • 3 months ago

Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Nuvation Bio Inc. (NYSE: NUVB). The investigation focuses on whether Nuvation Bio and its executive officers c... Full story

Yahoo Finance • 3 months ago

SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction

Key Points Knoll Capital Management bought 245,000 shares of SSR Mining. The quarter-end value of the SSR Mining position increased by $5.37 million due to the new purchase. The new SSR Mining position represents 2.46% of Knoll Capital Ma... Full story

Yahoo Finance • 3 months ago

Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy

Key Points Knoll Capital Management added 473,591 shares of Nuvation Bio in the fourth quarter; the estimated trade size was $2.93 million. Meanwhile, the quarter-end position value increased by $7.88 million, reflecting both additional s... Full story

Yahoo Finance • 3 months ago

Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships

Earnings Call Insights: Nuvation Bio Inc. (NUVB) Q4 2025 MANAGEMENT VIEW * David Hung, Founder, President, CEO & Chairman, highlighted that "2025 was a pivotal year for Nuvation Bio" due to the full U.S. FDA approval of IBTROZI for adv... Full story

Yahoo Finance • 3 months ago

Here are the major earnings after the close Monday

Major earnings expected after the bell on Monday include: * Plug Power (PLUG [https://seekingalpha.com/symbol/PLUG]) * Archer Aviation (ACHR [https://seekingalpha.com/symbol/ACHR]) * Credo Technology Group Holding Ltd (CRDO [https:/... Full story

Yahoo Finance • 3 months ago

Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?

Nuvation Bio Inc. (NYSE:NUVB) is one of the best small-cap stocks with huge growth potential. Nuvation Bio Inc. (NYSE:NUVB) announced on February 9 the finalization of a protocol amendment to the ongoing global SIGMA study of safusidenib t... Full story

Yahoo Finance • 4 months ago

Merchants Bancorp And 2 Other Growth Stocks Insiders Are Banking On

As the U.S. stock market kicks off February with a robust start, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing record highs, investors are keenly observing growth companies with significant insid... Full story

Yahoo Finance • 6 months ago

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatm... Full story

Yahoo Finance • 6 months ago

Nuvation Bio Shares Rise 8.4% After Positive Phase 2 Results In Grade-2 IDH1 Glioma

(RTTNews) - Nuvation Bio Inc. (NUVB) climbed 8.43%, rising $0.63 to $8.10, following the publication of favorable Phase 2 clinical trial results for its drug safusidenib in patients with grade-2 IDH1-mutant glioma. The data demonstrated p... Full story